前收市價 | 227.81 |
開市 | 227.39 |
買盤 | 228.62 x 900 |
賣出價 | 228.49 x 1200 |
今日波幅 | 227.39 - 230.86 |
52 週波幅 | 161.65 - 275.00 |
成交量 | |
平均成交量 | 541,401 |
市值 | 11.798B |
Beta 值 (5 年,每月) | 1.41 |
市盈率 (最近 12 個月) | 24.81 |
每股盈利 (最近 12 個月) | 9.23 |
業績公佈日 | 2024年5月09日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 270.80 |
Growth across Microbial Solutions and Biologics Testing businesses is likely to have contributed to Charles River's (CRL) Q1 revenues, offset by lower sales volume in the small model business.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Investors are optimistic about Charles River (CRL) owing to strength in RMS and DSA segments.